Table 3.
Summary of NGS results from all trophectoderm biopsy and miPGT samples obtained from the corresponding blastocyst.
| Embryo number |
TE biopsy | miPGT, ≥BB |
|---|---|---|
| Euploid-euploid | ||
| 1 | XX; normal | XX; normal |
| 2 | XX; normal | XX; normal |
| 3 | XX; normal | XX; normal |
| 4 | XX; normal | XX; normal |
| 5 | XX; normal | XX; normal |
| 6 | XX; normal | XX; normal |
| 7 | XX; normal | XX; normal |
| 8 | XY; normal | XY; normal |
| 9 | XX; normal | XX; normal |
| 10 | XX; normal | XX; normal |
| 11 | XY; normal | XY; normal |
| 12 | XY; normal | XY; normal |
| 13 | XX; normal | XX; normal |
| 14 | XY; normal | XY; normal |
| 15 | XY; normal | XY; normal |
| 16 | XY; normal | XY; normal |
| 17 | XY; normal | XY; normal |
| 18 | XX; normal | XX; normal |
| 19 | XY; normal | XY; normal |
| 20 | XY; normal | XY; normal |
| 21 | XX; normal | XX; normal |
| 22 | XY; normal | XY; normal |
| 23 | XY; normal | XY; normal |
| 24 | XX; normal | XX. normal |
| 25 | XY; normal | XY; normal |
| 26 | XX; normal | XX; normal |
| Euploid-mosaic | ||
| 27 | XY; normal | XY; mosaic −8 (70%) |
| 28 | XY; mosaic −9 (30%) | XY; normal |
| 29 | XX; mosaic −15 (20%) | XX; normal |
| 30 | XX; mosaic: −8p (35%), −9p (35%) | XX; normal |
| 31 | XX; normal | XX; mosaic −9 (70%) |
| Mosaic-mosaic | ||
| 32 | XY; mosaic −4q (118.6 Mb, 20%) | XY; mosaic +13q21.1 −q 31.3 (34.84 Mb, 60%) |
| 33 | XY; mosaic loss: (−4q22.1-q35.2, 100 Mb, 20%)* | XY; mosaic gain: (+4q 22.1-q35.2, 100 Mb, 30%)* |
| 34 | XY; mosaic: +8q (50%), −5q15-q35.3 (88MB, 35%) | XY; mosaic −3 (70%) |
| 35 | XY; mosaic −16 (60%) | XY; mosaic −17 (−70%) |
| 36 | XX; mosaic: +8 (50%), +19 (50%) | XX; mosaic: −17 (30%) |
| 37 | XX; mosaic: −22 (60%) | XX; mosaic: −22 (70%) |
| Segmental aneuploid-euploid | ||
| 38 | XX; normal | XX; −5q23.3-q35.3 (51.71 Mb) |
| Aneuploid-aneuploid | ||
| 39 | XX; −14 | XX; −14 |
| 40 | XX; −15 | XX; −15 |
| 41 | XY; +16, +21 | XY; +16, +21 |
| 42 | XX; +16 | XX; +16 |
| 43 | XY; −7, −15, −18 | XY; −7, −15, −18 |
| 44 | XX; −22 | XX; −22 |
| 45 | XX; −13 | XX; −13 |
| 46 | XY; +16 | XY; +16 |
| 47 | XY; −7 | XY; −7 |
| 48 | XY; +21 | XY; +21 |
|
Embryo number |
TE biopsy | miPGT, <BB |
| Euploid-euploid | ||
| 1 | XX; normal | XX; normal |
| 2 | XY; normal | XY; normal |
| 3 | XY; normal | XY; normal |
| 4 | XX; normal | XX; normal |
| 5 | XY; normal | XY; normal |
| 6 | XX; normal | XX; normal |
| 7 | XX; normal | XX; normal |
| 8 | XX; normal | XX; normal |
| 9 | XY; normal | XY; normal |
| 10 | XX; normal | XX; normal |
| 11 | XX; normal | XX; normal |
| 12 | XY; normal | XY; normal |
| 13 | XY; normal | XY; normal |
| 14 | XX; normal | XX; normal |
| 15 | XY; normal | XY; normal |
| 16 | XX; normal | XX; normal |
| 17 | XX; normal | XX; normal |
| Euploid-mosaic | ||
| 18 | XX; mosaic loss: (−3p.26.3 ± p25.2, 12 Mb, 35%) | XX; normal |
| 19 | XX; mosaic gain: +12p13.33-q23.3 (105.5 Mb, 45%) | XX; normal |
| 20 | XY; mosaic +16p (40%) | XY; normal |
| 21 | XX; mosaic −8 (40%) | XX; normal |
| Mosaic-mosaic | ||
| 22 |
XY; mosaic +6q22.1-q.25.2 (38.5 Mb, 45%), mosaic −15 (50%) |
XY; mosaic −8 (50%) |
| 23 | XY; mosaic loss: −3q26.31-q29 (24.4 Mb, 65%) | XY; mosaic loss: −3q26.31-q29 (24.4 Mb, 65%) |
| 24 | XX; mosaic: +4 (30%), +5 (30%), +8 (30%), +10 (50%) | XX; mosaic: +5 (40%), +10 (40%) |
| 25 | XY; mosaic + 14q11.2-q32.33, 84.69 Mb, 65%* | XY; mosaic −14q11.2-q32.33, 84.69 Mb, 60%* |
| 26 | XY; mosaic +4 (40%) | XY; mosaic +4 (50%) |
| Complex Aneuploid-mosaic | ||
| 27 | XX; −18 | XX; mosaic −18q12.2-q23 (43.75 Mb, 40%) |
| Aneuploid-aneuploid | ||
| 28 | XY; −5, −13 | XY; −5, −13 |
| 29 | XX; +19 | XX; +1919 |
| 30 | XY; +10, −11, −20 | XY; +10, −11, −20 |
| 31 | XY; +11, −16, +22 | XY; +9, +11, −16, +22 |
| 32 | XX; +22 | XX; +22 |
| 33 | XX; +13, +19, −21 | XX; +13, +19, −21 |
| 34 | XY; +11, mosaic gain: +10q23.31-26.3 (44.26MB, 50%) | XY; +10, +11, +16 |
| 35 | XX; −3p26.3-p22.1 (39, 8 Mb) | XX; −3p26.3-p22.1 (39, 8 Mb) |
| 36 | XY; −17, +21, mosaic: +1p31.1-p21.1 (39 Mb, 30%) | XY; −17, +21 |
| 37 | XY; −19 | XY; −19 |
| 38 | XY; −4, −8, +9, +18 | XY; −4, −8, +9, +18 |
| 39 | XY; +22 | XY; +22 |
| 40 | XX; −11 | XX; −11 |
| 41 | XY; −22 | XY; −22 |
| 42 | XY; +16 | XY; +16 |
*Mosaic-complementary in terms of chromosomal gain versus loss between TE biopsy and miPGT samples.
Blastocysts were grouped based on their static morphology in good if graded as ≥1/2 BB, or moderate/low if graded <1/2BB.